Meeting Reports of the Working Groups on inclusion into other programmatic areas (3.1) and

alignment of international cooperation with national plans (3.2)

WHO Global Coordination Mechanism on the Prevention and Control of NCDs

Thursday, 7 April 2016Salle C

Briefing Member States

WHO GCM/NCD

WHO Global Coordination Mechanismfor the Prevention and Control of NCDs

Conceptual framework

Terms of Reference

(adopted by the World Health

Assembly in 2014)

Work plan 2014-2015

(noted by the World Health Assembly in

2014)

Work plan 2016-2017

(noted by the World Health Assembly in

2015)

WHO Global Coordination Mechanism on NCDs

Scope and purpose:

Facilitate and enhance the coordination of activities, multi-stakeholder engagement and action across sectors at the local, national, regional and global levels, in order to contribute to the implementation of the WHO Global NCD Action Plan 2013 – 2020.

Member States

UN Agencies

Non-State Actors

Five functions: Advocating and raising

awareness

Disseminating knowledge and information

Encouraging innovation and identifying barriers

Advancing multisectoral action

Advocating for mobilization of resources

WHO Global Coordination Mechanism on NCDs

Working Groups Dialogues Virtual discussion forums Exchange of best practices Newsletters Webinars Communities of Practice Global communications campaign

Purpose and Terms of Reference for Working Groups

• In May 2014, the 68th WHA endorsed the GCM/NCD terms of reference and notedits 2016-2017 work plan, including establishment of three Working Groups.

• The TORs for the Working Groups spelt out (i) the process for nominating andappointing experts to the WGs; (ii) that Co-Chairs would be from developed anddeveloping Member States; and (iii) the working procedures

• The WHO GCM/NCD Working Groups are tasked with providing recommendationsto the WHO Director-General on ways and means of encouraging countries torealize the commitments made by Heads of State and Government at the 2011 UNGeneral Assembly High-level Meeting on NCDs and the UNGA outcome document2014

• The Working Groups can consult with relevant intergovernmental organizationsand non-State actors in their work.

5

WHO GCM/NCD

WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases

(GCM/NCD)

Working Group to recommend ways and means of encouraging Member States and non-State actors to promote the inclusion of the

prevention and control of noncommunicable diseases within responses to HIV/AIDS and programmes for sexual and reproductive health and

maternal and child health, as well as other communicable disease programmes, such as those on tuberculosis, including as part of wider

efforts to strengthen and orient health systems to address the prevention and control of noncommunicable diseases through

people-centred primary health care and universal health coverage.

WHO GCM/NCD

2011 United Nations General Assembly Political Declaration on NCDs

• In 2011 the United Nations General Assembly adopted the Political Declaration of the High-level Meeting of the United Nations General Assembly on the Prevention and Control of NCDs (resolution A/RES/66/2)

• Heads and representatives of States and Government committed to 30 (a) c-f(c) By 2016, as appropriate, strengthen and orient health systems to addressthe prevention and control of non-communicable diseases and the underlying social determinants through people-centred primary health care and universal throughout the life cycle, building on guidance set out in appendix 3 to theGlobal Action Plan;

(d) Consider the possible linkages between non-communicable diseases and some communicable diseases, such as HIV/AIDS, call for the integration, as appropriate, of responses to HIV/AIDS and non-communicable diseases, and in this regard call for attention to be given to people living with HIV/AIDS, especially in countries with a high prevalence of HIV/AIDS, in accordance with national priorities;

(e) Continue toto promote the inclusion of prevention and control of non-communicable diseases within programmes for sexual and reproductive health and maternal and child health, especially at the primary health-care level, as well as communicable disease programmes, such as those addressing tuberculosis, as appropriate;

(f) Consider the synergies between major non-communicable diseases and other conditions as described in appendix 1 to the Global Action Plan in order to develop a comprehensive response for the prevention and control of noncommunicable

diseases that also recognizes the conditions in which people live and work;

7

WHO GCM/NCD

Members of Working Group 3.1

1) Co-Chairs from a developed and developing country

• H.E. Beatriz Londono Soto, Ambassador Extraordinary and Plenipotentiary; Permanent Representative to the UNOG of Colombia

• Dr Naoko Yamamoto, Assistant Minister for Director Global Health, Ministry of Health, Labour and Welfare, Japan

2) Twelve members from each region of WHO

8

WHO GCM/NCD

•Dr Mariam AL-JALAHMA•Dr Marcia ERAZO •Ms Sanne FROST HELT•Dr Jonathan KLEIN•Dr Frances MCGRATH•Dr Dyah Erti MUSTIKAWATI

•Dr Kibachio Joseph Muiruri MWANGI •Professor Moffat J. NYIRENDA•Dr Mohammad Bin Yahya SAEEDI •Ms Anneli SAMMEL •Dr Mohammad SHAUKAT•Dr Rosalind VIANZON

WG 3.1 Meeting Schedule 2016 Overview

9

WHO GCM/NCD

1st meeting: 4-5 April 2016

3rd meeting: 26-27 September 2016 Discussion on the draft report Adoption of the report and submission to the Director-General of WHO

2nd meeting: 20-21 June 2016 Hearing with stakeholders and experts, including relevant non-State

actors Further discussion on WG’s recommendations

4th meeting : virtually if required

Circulation of interim report for comments by WG members Teleconference(s) if required to discuss draft report Circulate interim report with draft recommendations for

pubic comments

Collating additional information for 2nd meeting Contact parties for hearings during the 2nd meeting Public comment on background papers , collect

country cases and call for papers

WG 3.1 Key findings - Expectations

• Reemphasize political commitments made by Member States (2011, 2014, SDGs)

• Build on the many guidelines already available and translate them into implementable action at country level

• Identify a set of pre-requisites for effective integration at country-level

• Identify a clear definition of integration

• Identify convergences and commonalities between NCDs and specific programme areas and also across integrative initiatives

• Recommendations need to be country-led and country adaptable: ownership is essential

• Build a business case for integration, tailored for different audiences

• Integration of vertical programmes must be complemented by horizontal, community-based health system integration

• Recommendations should consider evidence-based innovations

• Identify co-morbidities and address shared risk factors between NCDs and other programme areas

• Integrative initiatives must include clear language for policy makers

10

WHO GCM/NCD

• Lack of evidence to construct a business case for integration for different audiences: patients, health professionals, policymakers, etc

• Lack of tools to help governments act on the business cases for integration

• Lack of leadership and poor coordination at country level on integrative initiatives

• Lack of a clear definition of integration

• Lack of monitoring and evaluation frameworks that assess impact of integration across programs

• Lack of clearly defined co-benefits of implementing best buys across programmes, e.g. co-benefits for NCD and HIV, NCD and TB, NCD and MCH, etc

• Advocating for integrated prevention programmes is particularly difficult

• Integration cannot be seen as the panacea; multisectoral coordination and collaboration must also be considered

11

WHO GCM/NCD

WG 3.1 Key findings - Barriers

WG 3.1 Key findings - Solutions• Local and community level focus: de-specialization towards community level

integrated service delivery, where appropriate

• Help governments form strong business cases for integration, targeting policy-makers, patients and health professionals

• Encourage strong Civil Society engagement, including patient advocacy, to help hold governments accountable

• Integration of NCDs should not be into but rather with other programme areas

• Draw on the strong HIV framework/platform/achievements

• Focus on guidance on how to translate policy into practice

• Entry points should be population based rather than program based

• Focus on social determinants of health in order to identify integrative entry points

• Identify co-morbidities and common risk factors between programmes and guide on providing an integrated, comprehensive service delivery

12

WHO GCM/NCD

WG 3.1 Meeting Schedule 2016

13

WHO GCM/NCD

2nd meeting: 20-21 June 2016

Objectives:• Substantive meeting to review evidence and conclusions from first meeting

and draft recommendations enhanced through expert participation and stakeholder consultations.

• Hearings with stakeholders, including non-State actors, through Webex.• Consider first draft of final report.• Discuss roll out/engagement plan with Member States (Working Group

members as advocates) and other stakeholder.

WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases

(GCM/NCD)

Working Group to recommend ways and means of encouraging Member States and non-State actors to align international cooperation on noncommunicable diseases

with national plans concerning noncommunicable diseases in order to strengthen aid effectiveness and the

development impact of external resources in support of noncommunicable diseases.

WHO GCM/NCD

Members of the Working Group

1) Two co-chairs representing developed and developing countries.

• H.E. Ambassador Taonga Mushayavanhu, Permanent Representative to the UNOG, Zimbabwe

• Mr Kjetil Aasland, Minister Counsellor for Health, Permanent Mission of Norway to the UNOG

2) Twelve members, two from each WHO region

15

WHO GCM/NCD

Dr Hussain Abdul Rahman AL RANDDr Mary AMUYUNZU-NYAMONGODr Nino BERDZULIDr Eduardo JARAMILLO NAVARRETEDr Guna Raj LOHANIProfessor Deborah MALTA

Professor Eva MARTOSProfessor Mohammad Reza MASJEDIDr Omar Bin MIHATDr Supattra SRIVANICHAKORNMr Lesley-Charles USURUAProfessor Wen-Qiang WEI

2011 United Nations General Assembly Political Declaration on NCDs

• In 2011 the United Nations General Assembly adopted the Political Declaration of the High-level Meeting of the United Nations General Assembly on the Prevention and Control of NCDs (resolution A/RES/66/2)

• Heads and representatives of States and Government committed to 30 (a)

(ix) Align international cooperation on non-communicable diseases with national plans concerning non-communicable diseases in order to strengthen aid effectiveness and the development impact of external resources in support of non-communicable diseases;

16

WHO GCM/NCD

WG 3.2 Meeting Schedule 2016 Overview

17

WHO GCM/NCD

1st meeting: 6-7 April 2016

3rd meeting: 28-29 September Discussion on the draft report Adoption of the report and submission to the Director-General of WHO

2nd meeting: 22-23 June 2016 Hearing with stakeholders and experts, including relevant non-State

actors Further discussion on WG’s recommendations

4th meeting : virtually if required

Circulation of interim report for comments by WG members Teleconference(s) if required to discuss draft report Circulate interim report with draft recommendations for

pubic comments

Collating additional information for 2nd meeting Contact parties for hearings during the 2nd meeting Public comment on background papers , collect

country cases and call for papers

WG 3.2 Key findings - Expectations

• Articulate clear recommendations that are easily adaptable to different countrycontexts

• Define international cooperation broader than traditional donor-recipient model toinclude collaboration across sectors and multi-stakeholder partnerships

• Advise on mechanism/platforms of engagement of international donors, as well asNGOs, civil society organizations and other relevant non-state actors, including theprivate sector

• Develop a guidance document that will address implementation challenges

• Provide innovative solutions using specific examples and sharing experiences fromthe WG members’ countries

18

WHO GCM/NCD

WG 3.2 Key findings - Barriers

• NCDs still not perceived as a developmental challenge

• NCD plans poorly aligned with internationally agreed targets and lack prioritization and costing

• Knowledge gap regarding multi-sectoral approaches

• Silo approach to NCDs – lack of integration and synergies

• Lack of resource mobilization efforts domestically and internationally

• Lack of awareness, activism and community engagement

19

WHO GCM/NCD

WG 3.2 Key findings - Solutions• Political power (e.g. laws and regulation)

• Social power (e.g. social movement, civil society engagement, activism, advocacy)

• Knowledge power (e.g. research, information, best practices, partnerships North-South, South-South)

• Mutual accountability (shared responsibility between donors and governments)

• National capacity building for integrated approaches

• Donor coordination mechanisms

20

WHO GCM/NCD

WG 3.2 Meeting Schedule 2016

21

WHO GCM/NCD

2nd meeting: 22-23 June 2016

Objectives:• Substantive meeting to review evidence and conclusions from

first meeting and draft recommendations enhanced through expert participation and stakeholder consultations

• Hearing with stakeholders, including non-state actors, throughWebex

• Consider first draft of final report• Discuss roll-out/engagement plan with Member States (Working

Group members as advocates) and other stakeholders

Thank You!

WHO Global Coordination Mechanism

http://www.who.int/global-coordination-mechanism/en/